I have only taken a couple of casual looks at ACL over the years, but I would rather buy and hold the out-and-out market leader with the track record to match for long periods.
Unless ACL is at a can’t-refuse kind of valuation, or SHL is egregiously valued (which it is not - kind of middle-of-the-road), sticking with the industry top dog is the way to go generally.
Ann: Half Yearly Report and Accounts, page-25
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$25.81 |
Change
0.470(1.85%) |
Mkt cap ! $12.39B | |||
| Open | High | Low | Value | Volume |
| $25.51 | $25.87 | $25.39 | $31.75M | 1.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 388 | $25.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $25.81 | 1 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$25.81 |
Change
0.470 ( 1.82 %) |
||||
| Open | High | Low | Volume | ||
| $25.46 | $25.86 | $25.39 | 227100 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| SHL (ASX) Chart |
